Harbour Lab

Pseudoangiomatous retinal gliosis (PARG) treated with iodine plaque in patient with chronic retinal detachment.

Marquez MA, Fortun J, Iyer P, Harbour JW, Haddock LJ, 2022 Sep Am J Ophthalmol Case Rep 27 101614

Hematologic Complications Associated With Intra-arterial Chemotherapy for Retinoblastoma Treatment: A Single Institution Experience.

Sanati-Mehrizy A, Ghosh T, Peterson E, Starke RM, Harbour JW, Corrales-Medina FF, 2022 May J Pediatr Hematol Oncol 4 44 181-185

HDAC11 activity contributes to MEK inhibitor escape in uveal melanoma.

Sriramareddy SN, Faião-Flores F, Emmons MF, Saha B, Chellappan S, Wyatt C, Smalley I, Licht JD, Durante MA, Harbour JW, Smalley KSM, 2022 Mar Cancer Gene Ther

Dissecting the Interplay Between Genetic Ancestry and Neighborhood Socioeconomic Status on Triple Negative Breast Cancer.

Goel N, Yadegarynia S, Kwon D, Kesmodel SB, Harbour JW, Kobetz E, Merchant N, Rodriguez DA, 2022 Jun Ann Surg

Pyruvate dehydrogenase inactivation causes glycolytic phenotype in BAP1 mutant uveal melanoma.

Han A, Chua V, Baqai U, Purwin TJ, Bechtel N, Hunter E, Tiago M, Seifert E, Speicher DW, Schug ZT, Harbour JW, Aplin AE, 2022 Jan Oncogene

Multi-omics profiling shows BAP1 loss is associated with upregulated cell adhesion molecules in uveal melanoma.

Baqai U, Purwin TJ, Bechtel N, Chua V, Han A, Hartsough EJ, Kuznetsoff JN, Harbour JW, Aplin AE, 2022 Apr Mol Cancer Res

Waking Up With Cloudy Vision.

Khine KT, Clark WM, Harbour JW, 2021 Oct JAMA Ophthalmol

Structural Protein Analysis of Driver Gene Mutations in Conjunctival Melanoma.

Djulbegovic MB, Uversky VN, Harbour JW, Galor A, Karp CL, 2021 Oct Genes (Basel) 10 12

Functional impact of titin (TTN) mutations in ocular surface squamous neoplasia.

Djulbegovic MB, Uversky VN, Karp CL, Harbour JW, 2021 Nov Int J Biol Macromol

Correction to: BAP1 mutant uveal melanoma is stratified by metabolic phenotypes with distinct vulnerability to metabolic inhibitors.

Han A, Purwin TJ, Bechtel N, Liao C, Chua V, Seifert E, Sato T, Schug ZT, Speicher DW, Harbour JW, Aplin AE, 2021 Mar Oncogene 9 40 1753

Comprehensive assessment of the effect of eye plaque tilt on tumor dosimetry.

Studenski MT, Markoe A, Samuels SE, Correa ZM, Bossart E, Harbour JW, 2021 Jun Brachytherapy

Iris metastasis from breast cancer successfully treated with Abemaciclib and Letrozole.

Goduni L, Ashkenazy N, Hansen E, Soyano-Muller A, Correa ZM, Harbour JW, 2021 Jun Retin Cases Brief Rep

Uphyloplot2: visualizing phylogenetic trees from single-cell RNA-seq data.

Kurtenbach S, Cruz AM, Rodriguez DA, Durante MA, Harbour JW, 2021 Jun BMC Genomics 1 22 419

Therapeutic Escape in Gaq-mutant Uveal Melanoma: It's a FAK.

Harbour JW, 2021 Jun Clin Cancer Res 11 27 2967-2969

Secondary Glaucoma Associated with Intraocular Metastatic Cutaneous Melanoma.

Greenfield JA, Rowlands M, Harbour JW, 2021 Jul Ophthalmol Glaucoma

Multiple genetically distinct uveal melanomas arise in the same eye of two patients with melanosis oculiUnilateral multifocal uveal melanoma in melanosis oculi.

Wagley S, Belin PJ, Dollar JJ, Harbour JW, Maltry AC, Mruthyunjaya P, Schefler AC, Tang PH, 2021 Jul Am J Ophthalmol

Iris Mass in a 14-Month-Old Boy.

Ashkenazy N, Walter SD, Harbour JW, 2021 Jul JAMA Ophthalmol 7 139 802-803

RETINOCYTOMA WITH VITREOUS SEEDING: NEW INSIGHTS FROM ENHANCED DEPTH IMAGING OPTICAL COHERENCE TOMOGRAPHY AND HIGH-RESOLUTION POSTERIOR SEGMENT ULTRASONOGRAPHY.

Garoon RB, Medina CA, Scelfo C, Harbour JW, 2021 Jan Retin Cases Brief Rep 1 15 68-70

Analytical Validation and Performance of a 7-Gene Next-Generation Sequencing Panel in Uveal Melanoma.

Alsina KM, Sholl LM, Covington KR, Arnal SM, Durante MA, Decatur CL, Stone JF, Oelschlager KM, Harbour JW, Monzon FA, Cook RW, Borman S, 2021 Dec Ocul Oncol Pathol 6 7 428-436

The AMP-dependent kinase pathway is upregulated in BAP1 mutant uveal melanoma.

Chua V, Han A, Bechtel N, Purwin TJ, Hunter E, Liao C, Harbour JW, Aplin AE, 2021 Aug Pigment Cell Melanoma Res

Kinetic Characterization of ASXL1/2-Mediated Allosteric Regulation of the BAP1 Deubiquitinase.

Peng H, Cassel J, McCracken DS, Prokop JW, Sementino E, Cheung M, Collop PR, Polo A, Joshi S, Mandell JP, Ayyanathan K, Hinds D, Malkowicz SB, Harbour JW, Bowcock AM, Salvino J, Kennedy EJ, Testa JR, Rauscher FJ, 2021 07 Mol Cancer Res 7 19 1099-1112

Multimodal Imaging in the Diagnosis of Exophytic Juxtapapillary Retinal Capillary Hemangioblastoma.

Russell JF, Villegas VM, Schwartz SG, Weng CY, Davis JL, Flynn HW, Harbour JW, 2021 05 Am J Ophthalmol 225 128-136

PieParty: visualizing cells from scRNA-seq data as pie charts.

Kurtenbach S, Dollar JJ, Cruz AM, Durante MA, Decatur CL, Harbour JW, 2021 05 Life Sci Alliance 5 4

Dual Screen for Efficacy and Toxicity Identifies HDAC Inhibitor with Distinctive Activity Spectrum for BAP1-Mutant Uveal Melanoma.

Kuznetsoff JN, Owens DA, Lopez A, Rodriguez DA, Chee NT, Kurtenbach S, Bilbao D, Roberts ER, Volmar CH, Wahlestedt C, Brothers SP, Harbour JW, 2021 02 Mol Cancer Res 2 19 215-222

Chimerism involving a RB1 pathogenic variant in monochorionic dizygotic twins with twin-twin transfusion syndrome.

Armitage AM, Kundra MA, Ghiam N, Atwal PS, Morel D, Hruska KS, Torene R, Harbour JW, Forghani I, 2021 01 Am J Med Genet A 1 185 208-212

Influence of tumor shape and location in eye plaque brachytherapy dosimetry.

Studenski MT, Patel NV, Markoe A, Harbour JW, Samuels SE, 2020 Mar - Apr Brachytherapy 2 19 249-254

Bilateral uveitis associated with nivolumab therapy for metastatic non-small cell lung cancer.

Dermarkarian CR, Patel NA, Villegas VM, Harbour JW, 2020 Jun Am J Ophthalmol Case Rep 18 100691

Multi-center analysis of intraocular biopsy technique and outcomes for uveal melanoma: Ocular Oncology Study Consortium report 4.

Seider MI, Berry DE, Schefler AC, Materin M, Stinnett S, Mruthyunjaya P, 2020 Feb Graefes Arch Clin Exp Ophthalmol 2 258 427-435

A novel cardiomyogenic role for Isl1+ neural crest cells in the inflow tract.

Hatzistergos KE, Durante MA, Valasaki K, Wanschel ACBA, Harbour JW, Hare JM, 2020 Dec Sci Adv 49 6

Use of a Modified Plastic Viewing System for Safer General Anesthesia Care in Pediatric Ophthalmic Surgery During the COVID-19 Pandemic.

Ashkenazy N, Orihuela G, Rodriguez LI, Negron CI, Harbour JW, Berrocal AM, 2020 11 Ophthalmic Surg Lasers Imaging Retina 11 51 651-652

Global Retinoblastoma Presentation and Analysis by National Income Level.

Fabian ID, Abdallah E, Abdullahi SU, Abdulqader RA, Adamou Boubacar S, Ademola-Popoola DS, Adio A, Afshar AR, Aggarwal P, Aghaji AE, Ahmad A, Akib MNR, Al Harby L, Al Ani MH, Alakbarova A, Portabella SA, Al-Badri SAF, Alcasabas APA, Al-Dahmash SA, Alejos A, Alemany-Rubio E, Alfa Bio AI, Alfonso Carreras Y, Al-Haddad C, Al-Hussaini HHY, Ali AM, Alia DB, Al-Jadiry MF, Al-Jumaily U, Alkatan HM, All-Eriksson C, Al-Mafrachi AARM, Almeida AA, Alsawidi KM, Al-Shaheen AASM, Al-Shammary EH, Amiruddin PO, Antonino R, Astbury NJ, Atalay HT, Atchaneeyasakul LO, Atsiaya R, Attaseth T, Aung TH, Ayala S, Baizakova B, Balaguer J, Balayeva R, Balwierz W, Barranco H, Bascaran C, Beck Popovic M, Benavides R, Benmiloud S, Bennani Guebessi N, Berete RC, Berry JL, Bhaduri A, Bhat S, Biddulph SJ, Biewald EM, Bobrova N, Boehme M, Boldt HC, Bonanomi MTBC, Bornfeld N, Bouda GC, Bouguila H, Boumedane A, Brennan RC, Brichard BG, Buaboonnam J, Calderón-Sotelo P, Calle Jara DA, Camuglia JE, Cano MR, Capra M, Cassoux N, Castela G, Castillo L, Català-Mora J, Chantada GL, Chaudhry S, Chaugule SS, Chauhan A, Chawla B, Chernodrinska VS, Chiwanga FS, Chuluunbat T, Cieslik K, Cockcroft RL, Comsa C, Correa ZM, Correa Llano MG, Corson TW, Cowan-Lyn KE, Csóka M, Cui X, Da Gama IV, Dangboon W, Das A, Das S, Davanzo JM, Davidson A, De Potter P, Delgado KQ, Demirci H, Desjardins L, Diaz Coronado RY, Dimaras H, Dodgshun AJ, Donaldson C, Donato Macedo CR, Dragomir MD, Du Y, Du Bruyn M, Edison KS, Eka Sutyawan IW, El Kettani A, Elbahi AM, Elder JE, Elgalaly D, Elhaddad AM, Elhassan MMA, Elzembely MM, Essuman VA, Evina TGA, Fadoo Z, Fandiño AC, Faranoush M, Fasina O, Fernández DDPG, Fernández-Teijeiro A, Foster A, Frenkel S, Fu LD, Fuentes-Alabi SL, Gallie BL, Gandiwa M, Garcia JL, García Aldana D, Gassant PY, Geel JA, Ghassemi F, Girón AV, Gizachew Z, Goenz MA, Gold AS, Goldberg-Lavid M, Gole GA, Gomel N, Gonzalez E, Gonzalez Perez G, González-Rodríguez L, Garcia Pacheco HN, Graells J, Green L, Gregersen PA, Grigorovski NDAK, Guedenon KM, Gunasekera DS, Gündüz AK, Gupta H, Gupta S, Hadjistilianou T, Hamel P, Hamid SA, Hamzah N, Hansen ED, Harbour JW, Hartnett ME, Hasanreisoglu M, Hassan S, Hassan S, Hederova S, Hernandez J, Hernandez LMC, Hessissen L, Hordofa DF, Huang LC, Hubbard GB, Hummlen M, Husakova K, Hussein Al-Janabi AN, Ida R, Ilic VR, Jairaj V, Jeeva I, Jenkinson H, Ji X, Jo DH, Johnson KP, Johnson WJ, Jones MM, Kabesha TBA, Kabore RL, Kaliki S, Kalinaki A, Kantar M, Kao LY, Kardava T, Kebudi R, Kepak T, Keren-Froim N, Khan ZJ, Khaqan HA, Khauv P, Kheir WJ, Khetan V, Khodabande A, Khotenashvili Z, Kim JW, Kim JH, Kiratli H, Kivelä TT, Klett A, Komba Palet JEK, Krivaitiene D, Kruger M, Kulvichit K, Kuntorini MW, Kyara A, Lachmann ES, Lam CPS, Lam GC, Larson SA, Latinovic S, Laurenti KD, Le BHA, Lecuona K, Leverant AA, Li C, Limbu B, Long QB, López JP, Lukamba RM, Lumbroso L, Luna-Fineman S, Lutfi D, Lysytsia L, Magrath GN, Mahajan A, Majeed AR, Maka E, Makan M, Makimbetov EK, Manda C, Martín Begue N, Mason L, Mason JO, Matende IO, Materin M, Mattosinho CCDS, Matua M, Mayet I, Mbumba FB, McKenzie JD, Medina-Sanson A, Mehrvar A, Mengesha AA, Menon V, Mercado GJVD, Mets MB, Midena E, Mishra DKC, Mndeme FG, Mohamedani AA, Mohammad MT, Moll AC, Montero MM, Morales RA, Moreira C, Mruthyunjaya P, Msina MS, Msukwa G, Mudaliar SS, Muma KI, Munier FL, Murgoi G, Murray TG, Musa KO, Mushtaq A, Mustak H, Muyen OM, Naidu G, Nair AG, Naumenko L, Ndoye Roth PA, Nency YM, Neroev V, Ngo H, Nieves RM, Nikitovic M, Nkanga ED, Nkumbe H, Nuruddin M, Nyaywa M, Obono-Obiang G, Oguego NC, Olechowski A, Oliver SCN, Osei-Bonsu P, Ossandon D, Paez-Escamilla MA, Pagarra H, Painter SL, Paintsil V, Paiva L, Pal BP, Palanivelu MS, Papyan R, Parrozzani R, Parulekar M, Pascual Morales CR, Paton KE, Pawinska-Wasikowska K, Pe'er J, Peña A, Peric S, Pham CTM, Philbert R, Plager DA, Pochop P, Polania RA, Polyakov VG, Pompe MT, Pons JJ, Prat D, Prom V, Purwanto I, Qadir AO, Qayyum S, Qian J, Rahman A, Rahman S, Rahmat J, Rajkarnikar P, Ramanjulu R, Ramasubramanian A, Ramirez-Ortiz MA, Raobela L, Rashid R, Reddy MA, Reich E, Renner LA, Reynders D, Ribadu D, Riheia MM, Ritter-Sovinz P, Rojanaporn D, Romero L, Roy SR, Saab RH, Saakyan S, Sabhan AH, Sagoo MS, Said AMA, Saiju R, Salas B, San Román Pacheco S, Sánchez GL, Sayalith P, Scanlan TA, Schefler AC, Schoeman J, Sedaghat A, Seregard S, Seth R, Shah AS, Shakoor SA, Sharma MK, Sherief ST, Shetye NG, Shields CL, Siddiqui SN, Sidi Cheikh S, Silva S, Singh AD, Singh N, Singh U, Singha P, Sitorus RS, Skalet AH, Soebagjo HD, Sorochynska T, Ssali G, Stacey AW, Staffieri SE, Stahl ED, Stathopoulos C, Stirn Kranjc B, Stones DK, Strahlendorf C, Suarez MEC, Sultana S, Sun X, Sundy M, Superstein R, Supriyadi E, Surukrattanaskul S, Suzuki S, Svojgr K, Sylla F, Tamamyan G, Tan D, Tandili A, Tarrillo Leiva FF, Tashvighi M, Tateshi B, Tehuteru ES, Teixeira LF, Teh KH, Theophile T, Toledano H, Trang DL, Traoré F, Trichaiyaporn S, Tuncer S, Tyau-Tyau H, Umar AB, Unal E, Uner OE, Urbak SF, Ushakova TL, Usmanov RH, Valeina S, van Hoefen Wijsard M, Varadisai A, Vasquez L, Vaughan LO, Veleva-Krasteva NV, Verma N, Victor AA, Viksnins M, Villacís Chafla EG, Vishnevskia-Dai V, Vora T, Wachtel AE, Wackernagel W, Waddell K, Wade PD, Wali AH, Wang YZ, Weiss A, Wilson MW, Wime ADC, Wiwatwongwana A, Wiwatwongwana D, Wolley Dod C, Wongwai P, Xiang D, Xiao Y, Yam JC, Yang H, Yanga JM, Yaqub MA, Yarovaya VA, Yarovoy AA, Ye H, Yousef YA, Yuliawati P, Zapata López AM, Zein E, Zhang C, Zhang Y, Zhao J, Zheng X, Zhilyaeva K, Zia N, Ziko OAO, Zondervan M, Bowman R, 2020 05 JAMA Oncol 5 6 685-695

Decitabine limits escape from MEK inhibition in uveal melanoma.

Gonçalves J, Emmons MF, Faião-Flores F, Aplin AE, Harbour JW, Licht JD, Wink MR, Smalley KSM, 2020 05 Pigment Cell Melanoma Res 3 33 507-514

Dosimetric comparison of circular Eye Physics and Collaborative Ocular Melanoma Study plaques to treat uveal melanoma.

Dean MK, Studenski MT, Paez-Escamilla MA, Walter SD, Kwon D, Markoe AM, Harbour JW, Samuels SE, 2019 May - Jun Brachytherapy 3 18 404-410

Vitreoretinal lymphoma followed by systemic diffuse large B cell lymphoma.

Fan KC, Tran KD, Harbour JW, Dubovy SA, Patel NA, Albini TA, 2019 Jun J Ophthalmic Inflamm Infect 1 9 11

Intraocular Metastasis in Unilateral Multifocal Uveal Melanoma Without Melanocytosis or Germline BAP1 Mutations.

Durante MA, Walter SD, Paez-Escamilla M, Tokarev J, Decatur CL, Dubovy SR, Schefler AC, Harbour JW, 2019 12 JAMA Ophthalmol 12 137 1434-1439

HDAC Inhibition Enhances the In Vivo Efficacy of MEK Inhibitor Therapy in Uveal Melanoma.

Faião-Flores F, Emmons MF, Durante MA, Kinose F, Saha B, Fang B, Koomen JM, Chellappan SP, Maria-Engler SS, Rix U, Licht JD, Harbour JW, Smalley KSM, 2019 09 Clin Cancer Res 18 25 5686-5701

Intraocular Dissemination of Uveal Melanoma Cells Following Radiotherapy: Evolving Management Over the Past Decade.

Paez-Escamilla M, Walter SD, Mohsenin A, Decatur CL, Harocopos GJ, Dubovy S, Harbour JW, 2019 09 Ophthalmic Surg Lasers Imaging Retina 9 50 573-579

Integrative Copy Number Analysis of Uveal Melanoma Reveals Novel Candidate Genes Involved in Tumorigenesis Including a Tumor Suppressor Role for PHF10/BAF45a.

Anbunathan H, Verstraten R, Singh AD, Harbour JW, Bowcock AM, 2019 08 Clin Cancer Res 16 25 5156-5166

CD4+/CD8+ immunophenotype switching as a marker for intraocular and CNS involvement in mycosis fungoides.

Husnain M, Mackrides N, Vega F, Paez-Escamilla M, Markoe AM, Harbour JW, Lossos IS, 2019 05 Leuk Lymphoma 5 60 1308-1311

An Eight-Year-Old Girl Presents With Two Weeks of Vision Loss and Nightly Headaches.

Scott NL, Tran KD, Cernichiaro-Espinosa LA, Russell JF, Hinkle JW, Harbour JW, Dubovy SR, Berrocal AM, 2019 05 Ophthalmic Surg Lasers Imaging Retina 5 50 314-317

Bilateral radiation therapy followed by methotrexate-based chemotherapy for primary vitreoretinal lymphoma.

de la Fuente MI, Alderuccio JP, Reis IM, Omuro A, Markoe A, Echegaray JJ, Davis JL, Harbour JW, Lossos IS, 2019 04 Am J Hematol 4 94 455-460

Longitudinal Examination of Fellow-Eye Vascular Anomalies in Coats' Disease With Widefield Fluorescein Angiography: A Multicenter Study.

Jeng-Miller KW, Soomro T, Scott NL, Rao P, Marlow E, Chang EY, Ells A, Chau F, Nudleman E, Calvo CM, Patel N, Schwartz R, Cernichiaro-Espinosa LA, Montoya AG, Goldstein J, Harper CA, Baumal CR, Hartnett ME, Harbour JW, Besirli CG, Gupta MP, Chan RVP, Drenser KA, Capone A, Murray TG, Mukai S, Trese MT, Berrocal AM, Wong SC, Yonekawa Y, 2019 04 Ophthalmic Surg Lasers Imaging Retina 4 50 221-227

Persistent fetal vasculature presenting with axial elongation and platyphakia.

Lin J, Paez-Escamilla M, Teira LE, Fallas B, Harbour JW, 2019 02 J AAPOS 1 23 51-53

ChIPprimersDB: a public repository of verified qPCR primers for chromatin immunoprecipitation (ChIP).

Kurtenbach S, Reddy R, Harbour JW, 2019 01 Nucleic Acids Res D1 47 D46-D49

Are Risk Factors for Growth of Choroidal Nevi Associated With Malignant Transformation? Assessment With a Validated Genomic Biomarker.

Harbour JW, Paez-Escamilla M, Cai L, Walter SD, Augsburger JJ, Correa ZM, 2019 01 Am J Ophthalmol 197 168-179

Follow the nevus: the cost-utility of monitoring for growth of choroidal nevi.

Barsam AS, Gibbons A, McClellan AJ, Harbour JW, Smiddy WE, 2019 Int J Ophthalmol 9 12 1456-1464

Retinoblastoma With Endophytic and Exophytic Features.

Paez-Escamilla M, Bagheri N, Harbour JW, 2018 Jan JAMA Ophthalmol 1 136 e175064

Drug and disease signature integration identifies synergistic combinations in glioblastoma.

Stathias V, Jermakowicz AM, Maloof ME, Forlin M, Walters W, Suter RK, Durante MA, Williams SL, Harbour JW, Volmar CH, Lyons NJ, Wahlestedt C, Graham RM, Ivan ME, Komotar RJ, Sarkaria JN, Subramanian A, Golub TR, Schürer SC, Ayad NG, 2018 12 Nat Commun 1 9 5315

Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide.

Walpole S, Pritchard AL, Cebulla CM, Pilarski R, Stautberg M, Davidorf FH, de la Fouchardière A, Cabaret O, Golmard L, Stoppa-Lyonnet D, Garfield E, Njauw CN, Cheung M, Turunen JA, Repo P, Järvinen RS, van Doorn R, Jager MJ, Luyten GPM, Marinkovic M, Chau C, Potrony M, Höiom V, Helgadottir H, Pastorino L, Bruno W, Andreotti V, Dalmasso B, Ciccarese G, Queirolo P, Mastracci L, Wadt K, Kiilgaard JF, Speicher MR, van Poppelen N, Kilic E, Al-Jamal RT, Dianzani I, Betti M, Bergmann C, Santagata S, Dahiya S, Taibjee S, Burke J, Poplawski N, O'Shea SJ, Newton-Bishop J, Adlard J, Adams DJ, Lane AM, Kim I, Klebe S, Racher H, Harbour JW, Nickerson ML, Murali R, Palmer JM, Howlie M, Symmons J, Hamilton H, Warrier S, Glasson W, Johansson P, Robles-Espinoza CD, Ossio R, de Klein A, Puig S, Ghiorzo P, Nielsen M, Kivelä TT, Tsao H, Testa JR, Gerami P, Stern MH, Paillerets BB, Abdel-Rahman MH, Hayward NK, 2018 12 J Natl Cancer Inst 12 110 1328-1341

Gene Expression Profiling and PRAME Status Versus Tumor-Node-Metastasis Staging for Prognostication in Uveal Melanoma.

Cai L, Paez-Escamilla M, Walter SD, Tarlan B, Decatur CL, Perez BM, Harbour JW, 2018 11 Am J Ophthalmol 195 154-160

Diagnosis of Bilateral Retinocytoma in an Adolescent Patient Using Multimodal Imaging and Genetic Testing.

Paez-Escamilla M, Walter SD, Ramaiya KJ, Harbour JW, 2018 10 Ophthalmic Surg Lasers Imaging Retina 10 49 812-814

Reduced BAP1 activity prevents ASXL1 truncation-driven myeloid malignancy in vivo.

Guo Y, Yang H, Chen S, Zhang P, Li R, Nimer SD, Harbour JW, Xu M, Yang FC, 2018 08 Leukemia 8 32 1834-1837

Anterior Chamber Chemotherapy in Retinoblastoma-Necessary But Not Sufficient for Aqueous Seeding Control-Reply.

Harbour JW, Paez-Escamilla M, 2018 05 JAMA Ophthalmol 5 136 597

Congenital Hypertrophy of the Retinal Pigment Epithelium Presenting With Secondary Choroidal Neovascularization.

Garoon RB, Harbour JW, 2018 04 Ophthalmic Surg Lasers Imaging Retina 4 49 276-277

Familial and Somatic BAP1 Mutations Inactivate ASXL1/2-Mediated Allosteric Regulation of BAP1 Deubiquitinase by Targeting Multiple Independent Domains.

Peng H, Prokop J, Karar J, Park K, Cao L, Harbour JW, Bowcock AM, Malkowicz SB, Cheung M, Testa JR, Rauscher FJ, 2018 03 Cancer Res 5 78 1200-1213

Gain of function of ASXL1 truncating protein in the pathogenesis of myeloid malignancies.

Yang H, Kurtenbach S, Guo Y, Lohse I, Durante MA, Li J, Li Z, Al-Ali H, Li L, Chen Z, Field MG, Zhang P, Chen S, Yamamoto S, Li Z, Zhou Y, Nimer SD, Harbour JW, Wahlestedt C, Xu M, Yang FC, 2018 01 Blood 3 131 328-341

Association between Tumor Regression Rate and Gene Expression Profile after Iodine 125 Plaque Radiotherapy for Uveal Melanoma.

Mruthyunjaya P, Seider MI, Stinnett S, Schefler A 2017 May Ophthalmology

ASXL1 interacts with the cohesin complex to maintain chromatid separation and gene expression for normal hematopoiesis.

Li Z, Zhang P, Yan A, Guo Z, Ban Y, Li J, Chen S, Yang H, He Y, Li J, Guo Y, Zhang W, Hajiramezanali E, An H, Fajardo D, Harbour JW, Ruan Y, Nimer SD, Yu P, Chen X, Xu M, Yang FC, 2017 Jan Sci Adv 1 3 e1601602

Prognostic Implications of the Largest Basal Tumor Diameter vs the TNM Staging System in Association With the Gene Expression Profile for Uveal Melanoma-Reply.

Harbour JW, 2017 Feb JAMA Ophthalmol 2 135 175-176

Intracameral Topotecan Hydrochloride for Anterior Chamber Seeding of Retinoblastoma.

Paez-Escamilla M, Bagheri N, Teira LE, Corrales-Medina FF, Harbour W, 2017 Dec JAMA Ophthalmol 12 135 1453-1454

Fluorescein angiography findings in diffuse retinoblastoma: two case reports with clinicopathologic correlation.

Fernandez MP, Al-Holou SN, Fischer O, Murray T, Harbour JW, Dubovy SR, Berrocal AM, 2017 Aug J AAPOS 4 21 337-339.e2

Molecular Characteristics of Conjunctival Melanoma Using Whole-Exome Sequencing.

Swaminathan SS, Field MG, Sant D, Wang G, Galor A, Dubovy SR, Harbour JW, Karp CL, 2017 12 JAMA Ophthalmol 12 135 1434-1437

Liquid Biopsy in Retinoblastoma.

Harbour JW, 2017 11 JAMA Ophthalmol 11 135 1231

Letter to the Editor: Comparison of Alternative Tumor Size Classifications for Posterior Uveal Melanomas.

Harbour JW, Paez-Escamilla M, 2017 10 Invest Ophthalmol Vis Sci 12 58 5444

Multimodal Imaging of Astrocytic Hamartomas Associated With Tuberous Sclerosis.

Schwartz SG, Harbour JW, 2017 09 Ophthalmic Surg Lasers Imaging Retina 9 48 756-758

Incorporating Clinical, Histological, and Genetic Parameters for Choroidal Melanoma Prognostication-Reply.

Harbour JW, 2017 07 JAMA Ophthalmol 7 135 819-820

Preclinical Acute Ocular Safety Study of Combined Intravitreal Carboplatin and Etoposide Phosphate for Retinoblastoma.

Mohney BG, Elner VM, Smith AB, Harbour JW, Smith BD, Musch DC, Smith SJ, 2017 02 Ophthalmic Surg Lasers Imaging Retina 2 48 151-159

An international survey of classification and treatment choices for group D retinoblastoma.

Scelfo C, Francis JH, Khetan V, Jenkins T, Marr B, Abramson DH, Shields CL, Pe'er J, Munier F, Berry J, Harbour JW, Yarovoy A, Lucena E, Murray TG, Bhagia P, Paysse E, Tuncer S, Chantada GL, Moll AC, Ushakova T, Plager DA, Ziyovuddin I, Leal CA, Materin MA, Ji XD, Cursino JW, Polania R, Kiratli H, All-Ericsson C, Kebudi R, Honavar SG, Vishnevskia-Dai V, Epelman S, Daniels AB, Ling JD, Traore F, Ramirez-Ortiz MA, 2017 Int J Ophthalmol 6 10 961-967

Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas.

Field MG, Durante MA, Decatur CL, Tarlan B, Oelschlager KM, Stone JF, Kuznetsov J, Bowcock AM, Kurtenbach S, Harbour JW, 2016 Sep Oncotarget 37 7 59209-59219

Prognostic Implications of Tumor Diameter in Association With Gene Expression Profile for Uveal Melanoma.

Walter SD, Chao DL, Feuer W, Schiffman J, Char DH, Harbour JW, 2016 Jul JAMA Ophthalmol 7 134 734-40

Uveal and Conjunctival Melanoma: Close Together-but Only Distantly Related.

Harbour JW, 2016 Jan Oncology (Williston Park) 1 30 44, 48

A rare case of leptomeningeal carcinomatosis in a patient with uveal melanoma: case report and review of literature.

Fedorenko IV, Evernden B, Kenchappa RS, Sahebjam S, Ryzhova E, Puskas J, McIntosh L, Caceres G, Magliocco A, Etame A, Harbour JW, Smalley KS, Forsyth PA, 2016 10 Melanoma Res 5 26 481-6

An Iris Tumor.

Rao RC, Harbour JW, 2016 09 JAMA Ophthalmol 9 134 1063-4

Driver Mutations in Uveal Melanoma: Associations With Gene Expression Profile and Patient Outcomes.

Decatur CL, Ong E, Garg N, Anbunathan H, Bowcock AM, Field MG, Harbour JW, 2016 07 JAMA Ophthalmol 7 134 728-33

The state of melanoma: challenges and opportunities.

Merlino G, Herlyn M, Fisher DE, Bastian BC, Flaherty KT, Davies MA, Wargo JA, Curiel-Lewandrowski C, Weber MJ, Leachman SA, Soengas MS, McMahon M, Harbour JW, Swetter SM, Aplin AE, Atkins MB, Bosenberg MW, Dummer R, Gershenwald JE, Halpern AC, Herlyn D, Karakousis GC, Kirkwood JM, Krauthammer M, Lo RS, Long GV, McArthur G, Ribas A, Schuchter L, Sosman JA, Smalley KS, Steeg P, Thomas NE, Tsao H, Tueting T, Weeraratna A, Xu G, Lomax R, Martin A, Silverstein S, Turnham T, Ronai ZA, 2016 07 Pigment Cell Melanoma Res 4 29 404-16

ARF6 Is an Actionable Node that Orchestrates Oncogenic GNAQ Signaling in Uveal Melanoma.

Yoo JH, Shi DS, Grossmann AH, Sorensen LK, Tong Z, Mleynek TM, Rogers A, Zhu W, Richards JR, Winter JM, Zhu J, Dunn C, Bajji A, Shenderovich M, Mueller AL, Woodman SE, Harbour JW, Thomas KR, Odelberg SJ, Ostanin K, Li DY, 2016 06 Cancer Cell 6 29 889-904

Spectral-Domain Optical Coherence Tomography of Presumed Solitary Circumscribed Retinal Astrocytic Proliferation Versus Astrocytic Hamartoma.

Schwartz SG, Harbour JW, 2015 May Ophthalmic Surg Lasers Imaging Retina 5 46 586-8

Skewed expression of the genes encoding epigenetic modifiers in high-risk uveal melanoma.

Herlihy N, Dogrusöz M, van Essen TH, Harbour JW, van der Velden PA, van Eggermond MC, Haasnoot GW, van den Elsen PJ, Jager MJ, 2015 Jan Invest Ophthalmol Vis Sci 3 56 1447-58

Hydroxyapatite versus polyethylene orbital implants for patients undergoing enucleation for uveal melanoma.

Chao DL, Harbour JW, 2015 Apr Can J Ophthalmol 2 50 151-4

Serous macular detachment following a systemic corticosteroid injection.

Weng CY, Harbour JW, 2015 Apr JAMA Ophthalmol 4 133 473-4

Epigenetic reprogramming of melanoma cells by vitamin C treatment.

Gustafson CB, Yang C, Dickson KM, Shao H, Van Booven D, Harbour JW, Liu ZJ, Wang G, 2015 Clin Epigenetics 7 51

EMT-associated factors promote invasive properties of uveal melanoma cells.

Asnaghi L, Gezgin G, Tripathy A, Handa JT, Merbs SL, van der Velden PA, Jager MJ, Harbour JW, Eberhart CG, 2015 Mol Vis 21 919-29

Combined PKC and MEK inhibition for treating metastatic uveal melanoma.

Sagoo MS, Harbour JW, Stebbing J, Bowcock AM, 2014 Sep Oncogene 39 33 4722-3

Distinguishing torpedo maculopathy from similar lesions of the posterior segment.

Villegas VM, Schwartz SG, Flynn HW, Capó H, Berrocal AM, Murray TG, Harbour JW, 2014 May-Jun Ophthalmic Surg Lasers Imaging Retina 3 45 222-6

Recent developments in prognostic and predictive testing in uveal melanoma.

Field MG, Harbour JW, 2014 May Curr Opin Ophthalmol 3 25 234-9

Outcomes of iodine-125 plaque brachytherapy for uveal melanoma with intraoperative ultrasonography and supplemental transpupillary thermotherapy.

Badiyan SN, Rao RC, Apicelli AJ, Acharya S, Verma V, Garsa AA, DeWees T, Speirs CK, Garcia-Ramirez J, Esthappan J, Grigsby PW, Harbour JW, 2014 Mar Int J Radiat Oncol Biol Phys 4 88 801-5

GNAQ/11 mutations in uveal melanoma: is YAP the key to targeted therapy?

Field MG, Harbour JW, 2014 Jun Cancer Cell 6 25 714-5

A molecular revolution in uveal melanoma: implications for patient care and targeted therapy.

Harbour JW, Chao DL, 2014 Jun Ophthalmology 6 121 1281-8

Prognostic parameters in uveal melanoma and their association with BAP1 expression.

van Essen TH, van Pelt SI, Versluis M, Bronkhorst IH, van Duinen SG, Marinkovic M, Kroes WG, Ruivenkamp CA, Shukla S, de Klein A, Kiliç E, Harbour JW, Luyten GP, van der Velden PA, Verdijk RM, Jager MJ, 2014 Dec Br J Ophthalmol 12 98 1738-43

Rapid regression of a subset of class 1 uveal melanomas after Iodine-125 plaque radiotherapy suggests an inflammatory mechanism.

Chen RW, Harbour JW, 2014 Dec Graefes Arch Clin Exp Ophthalmol 12 252 2021-2

A prognostic test to predict the risk of metastasis in uveal melanoma based on a 15-gene expression profile.

Harbour JW, 2014 Methods Mol Biol 1102 427-40

Molecular testing prognostic of low risk in epithelioid uveal melanoma in a child.

Dimaras H, Parulekar MV, Kwok G, Simpson ER, Ali A, Halliday W, Shago M, Harbour JW, Héon E, Gallie BL, Chan HS, 2013 Mar Br J Ophthalmol 3 97 323-6

Patient-derived xenografts recapitulate molecular features of human uveal melanomas.

Laurent C, Gentien D, Piperno-Neumann S, Némati F, Nicolas A, Tesson B, Desjardins L, Mariani P, Rapinat A, Sastre-Garau X, Couturier J, Hupé P, de Koning L, Dubois T, Roman-Roman S, Stern MH, Barillot E, Harbour JW, Saule S, Decaudin D, 2013 Jun Mol Oncol 3 7 625-36

Gene expression profiling versus TNM classification.

Harbour JW, Augsburger JJ, Char DH, 2013 Jul Ophthalmology 7 120 e52-3

Author reply: To PMID 22521086.

Harbour JW, Augsburger JJ, Char DH, 2013 Jul Ophthalmology 7 120 e51

Gene expressing profiling of iris melanomas.

Harbour JW, Wilson D, Finger PT, Worley LA, Onken MD, 2013 Jan Ophthalmology 1 120 213, 213.e1-3

A role for Jag2 in promoting uveal melanoma dissemination and growth.

Asnaghi L, Handa JT, Merbs SL, Harbour JW, Eberhart CG, 2013 Jan Invest Ophthalmol Vis Sci 1 54 295-306

Multimodal imaging of sarcoid choroidal granulomas.

Modi YS, Epstein A, Bhaleeya S, Harbour JW, Albini T, 2013 Aug J Ophthalmic Inflamm Infect 1 3 58

BAP1 deficiency causes loss of melanocytic cell identity in uveal melanoma.

Matatall KA, Agapova OA, Onken MD, Worley LA, Bowcock AM, Harbour JW, 2013 Aug BMC Cancer 13 371

The DecisionDx-UM Gene Expression Profile Test Provides Risk Stratification and Individualized Patient Care in Uveal Melanoma.

Harbour JW, Chen R, 2013 Apr PLoS Curr 5

Impaired cholesterol efflux in senescent macrophages promotes age-related macular degeneration.

Sene A, Khan AA, Cox D, Nakamura RE, Santeford A, Kim BM, Sidhu R, Onken MD, Harbour JW, Hagbi-Levi S, Chowers I, Edwards PA, Baldan A, Parks JS, Ory DS, Apte RS, 2013 Apr Cell Metab 4 17 549-61

Genomic, prognostic, and cell-signaling advances in uveal melanoma.

Harbour JW, 2013 Am Soc Clin Oncol Educ Book 388-91

High throughput mass spectrometry-based mutation profiling of primary uveal melanoma.

Daniels AB, Lee JE, MacConaill LE, Palescandolo E, Van Hummelen P, Adams SM, DeAngelis MM, Hahn WC, Gragoudas ES, Harbour JW, Garraway LA, Kim IK, 2012 Oct Invest Ophthalmol Vis Sci 11 53 6991-6

The genetics of uveal melanoma: an emerging framework for targeted therapy.

Harbour JW, 2012 Mar Pigment Cell Melanoma Res 2 25 171-81

Update in uveal melanoma.

Harbour JW, 2012 Jul Clin Adv Hematol Oncol 7 10 459-61

Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.

Landreville S, Agapova OA, Matatall KA, Kneass ZT, Onken MD, Lee RS, Bowcock AM, Harbour JW, 2012 Jan Clin Cancer Res 2 18 408-16

Notch signaling promotes growth and invasion in uveal melanoma.

Asnaghi L, Ebrahimi KB, Schreck KC, Bar EE, Coonfield ML, Bell WR, Handa J, Merbs SL, Harbour JW, Eberhart CG, 2012 Feb Clin Cancer Res 3 18 654-65

Uveal melanoma: molecular pattern, clinical features, and radiation response.

Chappell MC, Char DH, Cole TB, Harbour JW, Mishra K, Weinberg VK, Phillips TL, 2012 Aug Am J Ophthalmol 2 154 227-232.e2

Diagnostic testing and treatment choices in primary vitreoretinal lymphoma.

Rajagopal R, Harbour JW, 2011 Mar Retina 3 31 435-40

ABCB1 identifies a subpopulation of uveal melanoma cells with high metastatic propensity.

Landreville S, Agapova OA, Kneass ZT, Salesse C, Harbour JW, 2011 Jun Pigment Cell Melanoma Res 3 24 430-7

A new mutation with staggering effects.

Harbour JW, 2011 Dec Pigment Cell Melanoma Res 6 24 1081-2

Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium.

Chan CC, Rubenstein JL, Coupland SE, Davis JL, Harbour JW, Johnston PB, Cassoux N, Touitou V, Smith JR, Batchelor TT, Pulido JS, 2011 Oncologist 11 16 1589-99

Association between gene expression profile, proliferation and metastasis in uveal melanoma.

Onken MD, Worley LA, Harbour JW, 2010 Sep Curr Eye Res 9 35 857-63

Loss of Id2 potentiates the tumorigenic effect of Rb inactivation in a mouse model of retinoblastoma.

Landreville S, Ma D, Wu J, Harbour JW, 2010 May Curr Eye Res 5 35 435-9

A transformation in ocular oncology: from megacenter to multicenter.

Harbour JW, 2010 Mar Arch Ophthalmol 3 128 367-8

Review of 676 second primary tumors in patients with retinoblastoma: association between age at onset and tumor type.

Woo KI, Harbour JW, 2010 Jul Arch Ophthalmol 7 128 865-70

Id2 deficiency promotes metastasis in a mouse model of ocular cancer.

Agapova OA, Person E, Harbour JW, 2010 Feb Clin Exp Metastasis 2 27 91-6

Hepatic metastasis from uveal melanoma: angiographic pattern predictive of survival after hepatic arterial chemoembolization.

Dayani PN, Gould JE, Brown DB, Sharma KV, Linette GP, Harbour JW, 2009 May Arch Ophthalmol 5 127 628-32

Molecular prognostic testing and individualized patient care in uveal melanoma.

Harbour JW, 2009 Dec Am J Ophthalmol 6 148 823-9.e1

The 7th edition AJCC staging system for eye cancer: an international language for ophthalmic oncology.

Finger PT, 2009 Aug Arch Pathol Lab Med 8 133 1197-8

Emerging insights into the molecular pathogenesis of uveal melanoma.

Landreville S, Agapova OA, Harbour JW, 2008 Oct Future Oncol 5 4 629-36

Correlation study of benign cytomorphology and final clinical diagnosis.

Zhai J, Harbour JW, Smith ME, Dávila RM, 2008 Mar-Apr Acta Cytol 2 52 196-200

Prognostic biomarkers in uveal melanoma: evidence for a stem cell-like phenotype associated with metastasis.

Chang SH, Worley LA, Onken MD, Harbour JW, 2008 Jun Melanoma Res 3 18 191-200

Micro-RNAs associated with metastasis in uveal melanoma identified by multiplexed microarray profiling.

Worley LA, Long MD, Onken MD, Harbour JW, 2008 Jun Melanoma Res 3 18 184-90

Hepatic arterial chemoembolization for management of metastatic melanoma.

Sharma KV, Gould JE, Harbour JW, Linette GP, Pilgram TK, Dayani PN, Brown DB, 2008 Jan AJR Am J Roentgenol 1 190 99-104

Tilting of radioactive plaques after initial accurate placement for treatment of uveal melanoma.

Almony A, Breit S, Zhao H, Garcia-Ramirez J, Mansur DB, Harbour JW, 2008 Jan Arch Ophthalmol 1 126 65-70

Integrative genomic analysis of aneuploidy in uveal melanoma.

Ehlers JP, Worley L, Onken MD, Harbour JW, 2008 Jan Clin Cancer Res 1 14 115-22

Oncogenic mutations in GNAQ occur early in uveal melanoma.

Onken MD, Worley LA, Long MD, Duan S, Council ML, Bowcock AM, Harbour JW, 2008 Dec Invest Ophthalmol Vis Sci 12 49 5230-4

Comment on "Lowpenetrant RB allele in small-cell cancer shows geldanamycin instability and discordant expression with mutant ras" by Park et al.

Harbour JW, 2008 Aug Cell Cycle 15 7 2276-7

Treatment outcomes for primary intraocular lymphoma: implications for external beam radiotherapy.

Berenbom A, Davila RM, Lin HS, Harbour JW, 2007 Sep Eye (Lond) 9 21 1198-201

Loss of heterozygosity of chromosome 3 detected with single nucleotide polymorphisms is superior to monosomy 3 for predicting metastasis in uveal melanoma.

Onken MD, Worley LA, Person E, Char DH, Bowcock AM, Harbour JW, 2007 May Clin Cancer Res 10 13 2923-7

Transcriptomic versus chromosomal prognostic markers and clinical outcome in uveal melanoma.

Worley LA, Onken MD, Person E, Robirds D, Branson J, Char DH, Perry A, Harbour JW, 2007 Mar Clin Cancer Res 5 13 1466-71

Molecular prognostic testing in uveal melanoma: has it finally come of age?

Harbour JW, 2007 Aug Arch Ophthalmol 8 125 1122-3

Inhibiting angiogenesis in retinoblastoma.

Apte RS, Harbour JW, 2007 Ophthalmic Res 4 39 188-90

Rb at the interface between cell cycle and apoptotic decisions.

Delston RB, Harbour JW, 2006 Nov Curr Mol Med 7 6 713-8

Prognostic testing in uveal melanoma by transcriptomic profiling of fine needle biopsy specimens.

Onken MD, Worley LA, Dávila RM, Char DH, Harbour JW, 2006 Nov J Mol Diagn 5 8 567-73

Lipid exudation following plaque radiotherapy for posterior uveal melanoma.

Mills MD, Harbour JW, 2006 Mar Am J Ophthalmol 3 141 594-595

Molecular pathobiology of uveal melanoma.

Ehlers JP, Harbour JW, 2006 Int Ophthalmol Clin 1 46 167-80

Association between microarray gene expression signature and extravascular matrix patterns in primary uveal melanomas.

Onken MD, Lin AY, Worley LA, Folberg R, Harbour JW, 2005 Oct Am J Ophthalmol 4 140 748-9

Fine needle aspiration biopsy with adjunct immunohistochemistry in intraocular tumor management.

Faulkner-Jones BE, Foster WJ, Harbour JW, Smith ME, Dávila RM, 2005 May-Jun Acta Cytol 3 49 297-308

Functional analysis of the p53 pathway in response to ionizing radiation in uveal melanoma.

Sun Y, Tran BN, Worley LA, Delston RB, Harbour JW, 2005 May Invest Ophthalmol Vis Sci 5 46 1561-4

DDEF1 is located in an amplified region of chromosome 8q and is overexpressed in uveal melanoma.

Ehlers JP, Worley L, Onken MD, Harbour JW, 2005 May Clin Cancer Res 10 11 3609-13

Loss of Rb-E2F repression results in caspase-8-mediated apoptosis through inactivation of focal adhesion kinase.

Lieman JH, Worley LA, Harbour JW, 2005 Mar J Biol Chem 11 280 10484-90

NBS1 expression as a prognostic marker in uveal melanoma.

Ehlers JP, Harbour JW, 2005 Mar Clin Cancer Res 5 11 1849-53

Uveal melanoma: genetic aspects.

Singh AD, Damato B, Howard P, Harbour JW, 2005 Mar Ophthalmol Clin North Am 1 18 85-97, viii

What is the best treatment for retinoblastoma?

Harbour JW, 2004 Sep Am J Ophthalmol 3 138 471-3

Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death.

Onken MD, Worley LA, Ehlers JP, Harbour JW, 2004 Oct Cancer Res 20 64 7205-9

For whom the bell tolls: susceptibility to common adult cancers in retinoblastoma survivors.

Kaye FJ, Harbour JW, 2004 Mar J Natl Cancer Inst 5 96 342-3

Photodynamic therapy for choroidal metastasis from carcinoid tumor.

Harbour JW, 2004 Jun Am J Ophthalmol 6 137 1143-5

Cytologic diagnosis of intraocular lymphoma in vitreous aspirates.

Farkas T, Harbour JW, Dávila RM, 2004 Jul-Aug Acta Cytol 4 48 487-91

Optical coherence tomography in the evaluation of retinal changes associated with suspicious choroidal melanocytic tumors.

Espinoza G, Rosenblatt B, Harbour JW, 2004 Jan Am J Ophthalmol 1 137 90-5

Association between choroidal pigmentation and posterior uveal melanoma in a white population.

Harbour JW, Brantley MA, Hollingsworth H, Gordon M, 2004 Jan Br J Ophthalmol 1 88 39-43

Association between posterior uveal melanoma and iris freckles, iris naevi, and choroidal naevi.

Harbour JW, Brantley MA, Hollingsworth H, Gordon M, 2004 Jan Br J Ophthalmol 1 88 36-8

Pars plana vitrectomy in eyes containing a treated posterior uveal melanoma.

Foster WJ, Harbour JW, Holekamp NM, Shah GK, Thomas MA, 2003 Sep Am J Ophthalmol 3 136 471-6

Status of the NF1 tumor suppressor locus in uveal melanoma.

Foster WJ, Fuller CE, Perry A, Harbour JW, 2003 Sep Arch Ophthalmol 9 121 1311-5

Transpupillary thermotherapy versus plaque radiotherapy for suspected choroidal melanomas.

Harbour JW, Meredith TA, Thompson PA, Gordon ME, 2003 Nov Ophthalmology 11 110 2207-14; discussion 2215

Ocular melanoma: a review and the relationship to cutaneous melanoma.

Hurst EA, Harbour JW, Cornelius LA, 2003 Aug Arch Dermatol 8 139 1067-73

Molecular genetics of uveal melanoma.

Loercher AE, Harbour JW, 2003 Aug Curr Eye Res 2 27 69-74

Transducible peptide therapy for uveal melanoma and retinoblastoma.

Harbour JW, Worley L, Ma D, Cohen M, 2002 Oct Arch Ophthalmol 10 120 1341-6

Rate of resolution of exudative retinal detachment after plaque radiotherapy for uveal melanoma.

Harbour JW, Ahmad S, El-Bash M, 2002 Nov Arch Ophthalmol 11 120 1463-9

Risk factors for metastasis in retinoblastoma.

Finger PT, Harbour JW, Karcioglu ZA, 2002 Jan-Feb Surv Ophthalmol 1 47 1-16

Altered expression of Rb and p53 in uveal melanomas following plaque radiotherapy.

Brantley MA, Worley L, Harbour JW, 2002 Feb Am J Ophthalmol 2 133 242-8

Photodynamic therapy for circumscribed choroidal hemangioma.

Sheidow TG, Harbour JW, 2002 Aug Can J Ophthalmol 5 37 314-7

Molecular basis of low-penetrance retinoblastoma.

Harbour JW, 2001 Nov Arch Ophthalmol 11 119 1699-704

The molecular biology of retinoblastoma.

Brantley MA, Harbour JW, 2001 Mar Ocul Immunol Inflamm 1 9 1-8

Corepressors and retinoblastoma protein function.

Harbour JW, Dean DC, 2001 Curr Top Microbiol Immunol 254 137-44

The Rb/E2F pathway: expanding roles and emerging paradigms.

Harbour JW, Dean DC, 2000 Oct Genes Dev 19 14 2393-409

Deregulation of the Rb and p53 pathways in uveal melanoma.

Brantley MA, Harbour JW, 2000 Dec Am J Pathol 6 157 1795-801

Chromatin remodeling and Rb activity.

Harbour JW, Dean DC, 2000 Dec Curr Opin Cell Biol 6 12 685-9

Rb function in cell-cycle regulation and apoptosis.

Harbour JW, Dean DC, 2000 Apr Nat Cell Biol 4 2 E65-7

Tumor suppressor genes in ophthalmology.

Harbour JW, 1999 Nov-Dec Surv Ophthalmol 3 44 235-46

Overview of RB gene mutations in patients with retinoblastoma. Implications for clinical genetic screening.

Harbour JW, 1998 Aug Ophthalmology 8 105 1442-7

Langerhans cell histiocytosis diagnosed by fine needle biopsy.

Harbour JW, Char DH, Ljung BM, Luna-Fineman S, 1997 Sep Arch Ophthalmol 9 115 1212-3

Metastatic risk for distinct patterns of postirradiation local recurrence of posterior uveal melanoma.

Harbour JW, Char DH, Kroll S, Quivey JM, Castro J, 1997 Nov Ophthalmology 11 104 1785-92; discussion 1792-3

Pars plana vitrectomy in the management of phakic and pseudophakic malignant glaucoma.

Harbour JW, Rubsamen PE, Palmberg P, 1996 Sep Arch Ophthalmol 9 114 1073-8

Local carboplatin therapy in transgenic murine retinoblastoma.

Harbour JW, Murray TG, Hamasaki D, Cicciarelli N, Hernández E, Smith B, Windle J, O'Brien JM, 1996 Aug Invest Ophthalmol Vis Sci 9 37 1892-8

Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane.

Harbour JW, Smiddy WE, Flynn HW, Rubsamen PE, 1996 Apr Am J Ophthalmol 4 121 405-13

Intraoperative echographic localization of iodine 125 episcleral radioactive plaques for posterior uveal melanoma.

Harbour JW, Murray TG, Byrne SF, Hughes JR, Gendron EK, Ehlies FJ, Markoe AM, 1996 Retina 2 16 129-34

Pars plana vitrectomy for chronic pseudophakic cystoid macular edema.

Harbour JW, Smiddy WE, Rubsamen PE, Murray TG, Davis JL, Flynn HW, 1995 Sep Am J Ophthalmol 3 120 302-7

Initial management and follow-up of melanocytic iris tumors.

Harbour JW, Augsburger JJ, Eagle RC, 1995 Dec Ophthalmology 12 102 1987-93

Uveal metastasis from carcinoid tumor. Clinical observations in nine cases.

Harbour JW, De Potter P, Shields CL, Shields JA, 1994 Jun Ophthalmology 6 101 1084-90

Clivus chordoma: a report of 12 recent cases and review of the literature.

Harbour JW, Lawton MT, Criscuolo GR, Holliday MJ, Mattox DE, Long DM, 1991 Skull Base Surg 4 1 200-6

Expression in lung cancer of a transcribed sequence at the DNF15S2 locus at chromosome 3P21.

Harbour JW, Lai SL, Gazdar AF, Minna JD, Kaye FJ, 1990 Jan-Feb Anticancer Res 1 10 23-7

Loss of heterozygosity in a gene coding for a thyroid hormone receptor in lung cancers.

Leduc F, Brauch H, Hajj C, Dobrovic A, Kaye F, Gazdar A, Harbour JW, Pettengill OS, Sorenson GD, van den Berg A, 1989 Feb Am J Hum Genet 2 44 282-7